Role of radiotherapy in diffuse large B‐cell lymphoma in advanced stages on complete response after administration of cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab

Role of radiotherapy in diffuse large B‐cell lymphoma in advanced stages on complete response after administration of cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab

Abstract Objective The role of radiotherapy (RT) as adjuvant therapy in patients with diffuse large B‐cell lymphoma and nodal bulky disease at diagnosis remains unclear. Thus, we carried out an open‐label clinical trial to assess if RT in patients with complete response after immunochemotherapy (rit...

Full description

Bibliographic Details
Main Authors:	Agustin Aviles, Angel Calva, Natividad Neri, Sergio Cleto, Luis Silva
Format:	Article
Language:	English
Published:	Wiley 2019-09-01
Series:	Precision Radiation Oncology
Subjects:	chemotherapy diffuse large B‐cell lymphoma radiotherapy rituximab
Online Access:	https://doi.org/10.1002/pro6.1071

Similar Items

Radiotherapy after immunochemotherapy improves outcomes in patients with primary mediastinal large B‐cell lymphoma
by: Agustin Avilés, et al.
Published: (2019-12-01)

Intravitreal rituximab for the treatment of a secondary intraocular relapse of a large B-cell lymphoma
by: Jose J. Echegaray, et al.
Published: (2018-03-01)

Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma
by: Myrna Candelaria, et al.
Published: (2021-01-01)

Clinical Findings and Treatment Results in Ocular Adnexal Lymphomas
by: Feyza Çalış, et al.
Published: (2014-10-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma
by: T. D. Lutskaya, et al.
Published: (2014-07-01)

A Descriptive Study of 103 Primary Cutaneous B-Cell Lymphomas: Clinical and Pathological Characteristics and Treatment from the Spanish Lymphoma Oncology Group (GOTEL)
by: Natividad Martínez-Banaclocha, et al.
Published: (2024-03-01)

Altered Regional Brain Glucose Metabolism in Diffuse Large B-Cell Lymphoma Patients Treated With Cyclophosphamide, Epirubicin, Vincristine, and Prednisone: An Fluorodeoxyglucose Positron Emission Tomography Study of 205 Cases
by: Yuxiao Hu, et al.
Published: (2022-06-01)

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lymphoma
by: Patrick B. Johnston, et al.
Published: (2021-02-01)

Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
by: R. A. Golubenko, et al.
Published: (2014-07-01)

Experience of using rituximab for recurrent non-Hodgkin lymphoma in elderly patients of the Orel region
by: R. A. Golubenko, et al.
Published: (2014-07-01)

Sciatic diffuse large B-cell lymphoma with treatment response to CHOP and radiotherapy
by: Firoozeh Shomal Zadeh, MD, et al.
Published: (2024-01-01)

Cardiovascular adverse events associated with cyclophosphamide, pegylated liposomal doxorubicin, vincristine, and prednisone with or without rituximab ((R)-CDOP) in non-Hodgkin’s lymphoma: A systematic review and meta-analysis
by: Bin Lu, et al.
Published: (2022-12-01)

Rituximab Maintenance Strategy in Advanced Follicular Lymphoma: Facts and Controversies
by: Vibor Milunović, et al.
Published: (2017-01-01)

The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients
by: Alessandro Broccoli, et al.
Published: (2017-04-01)

Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing
by: Min Ji Jeon, et al.
Published: (2023-11-01)

Diagnosis and Treatment for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma
by: Shotaro Nakamura, et al.
Published: (2022-12-01)

Addition of Rituximab Significantly Improves Outcomes in Patients with Diffuse Large B-cell Lymphoma – a Single-center, Retrospective Study
by: David Belada, et al.
Published: (2007-01-01)

Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis
by: Xiaoxuan Lu, et al.
Published: (2022-12-01)

Minimising chemotherapy while optimising immune therapy for paediatric nodular lymphocyte-predominant Hodgkin's lymphoma
by: Roiya Farhan, MBBS, et al.
Published: (2020-12-01)

The Role of Rituximab in Lymphomas
by: Bertrand Coiffier
Published: (2002-01-01)

Intralesional and systemic rituximab in the treatment of primary cutaneous B‐cell lymphoma
by: Jake G. Besch‐Stokes, et al.
Published: (2023-12-01)

Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience
by: Murat Özbalak, et al.
Published: (2022-11-01)

An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era
by: Feifei Sun, et al.
Published: (2018-01-01)

Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience
by: Roland Christian Schelker, et al.
Published: (2018-10-01)

Rituximab Treatment Strategy for Patients with Diffuse Large B-Cell Lymphoma after First-Line Therapy: A Systematic Review and Meta-Analysis
by: Yuan-Rong Ren, et al.
Published: (2015-01-01)

Current approaches to the treatment of non-Hodgkin's lymphoma
by: Christian Gisselbrecht
Published: (2011-10-01)

Outcome of primary orbital lymphoma treated with induction chemotherapy followed by conformal radiotherapy
by: Supriya Mallick, et al.
Published: (2015-09-01)

Treatment of haemophagocytic lymphohistiocytosis with cyclophosphamide, vincristine and prednisone
by: Yixin Hu, et al.
Published: (2012-01-01)

Rituximab for the first-line treatment of stage III–IV follicular lymphoma (review of Technology Appraisal No. 110): a systematic review and economic evaluation
by: D Papaioannou, et al.
Published: (2012-09-01)

Emerging Role of Consolidative Radiotherapy After Complete Remission Following R-CHOP Immunochemotherapy in Stage III–IV Diffuse Large B-Cell Lymphoma: A Single Institutional and Case-Matched Control Study
by: Ji Hyun Hong, et al.
Published: (2021-02-01)

A phase III, multicentric, open-label, two-arm, parallel group, active-control, randomized, comparative clinical study to evaluate efficacy and safety of RituxiRel™ arm (rituximab) with reference arm (rituximab) in patients with non-Hodgkin's lymphoma
by: Prasad Dattatray Apsangikar, et al.
Published: (2017-01-01)

Linfoma hepático primario: Evolución favorable con quimioterapia combinada con rituximab Primary hepatic lymphoma: favorable outcome with chemotherapy plus rituximab
by: I. Serrano-Navarro, et al.
Published: (2008-11-01)

Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group
by: Naoki Wada, et al.
Published: (2009-10-01)

A randomized, open-label, Phase III study of obinutuzumab or rituximab plus CHOP in patients with previously untreated diffuse large B-Cell lymphoma: final analysis of GOYA
by: Laurie H. Sehn, et al.
Published: (2020-06-01)

Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP
by: Kyoung Min Cho, et al.
Published: (2019-07-01)

Orbital lymphoma
by: Baskararajan Gopalakrishnan, et al.
Published: (2017-01-01)

Effectiveness and Adverse Events of Cyclophosphamide, Vincristine, and Prednisolone Chemotherapy in Feline Mediastinal Lymphoma Naturally Infected with Feline Leukemia Virus
by: Supita Sunpongsri, et al.
Published: (2022-03-01)

Primary breast lymphoma: A single-institute experience in Taiwan
by: Che-Wei Ou, et al.
Published: (2014-10-01)

Primary bone lymphoma: A clinicopathological retrospective study of 28 patients in a single institution
by: Mohammad Reza Ghavam Nasiri, et al.
Published: (2011-01-01)